Kabivitrum

Kabivitrum Brand names, Kabivitrum Analogs

Kabivitrum Brand Names Mixture

No information avaliable

Kabivitrum Chemical_Formula

C₁₆H₁₃ClN₂O

Kabivitrum RX_link

http://www.rxlist.com/cgi/generic/diazepam.htm

Kabivitrum fda sheet

Kabivitrum msds (material safety sheet)

Kabivitrum MSDS

Kabivitrum Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Kabivitrum Molecular Weight

284.74 g/mol

Kabivitrum Melting Point

125-126^oC

Kabivitrum H₂O Solubility

Slightly soluble (50 mg/L)

Kabivitrum State

solid

Kabivitrum LogP

2.988

Kabivitrum Dosage Forms

Tablets; Injectable solution

Kabivitrum Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Kabivitrum Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Kabivitrum Absorption

Essentially complete, with a bioavailability of 93%.

Kabivitrum side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Kabivitrum Patient Information

Kabivitrum Organisms Affected

Humans and other mammals